Granahan Investment Management’s Enzo Biochem, Inc. ENZ Stock Holding History

Granahan Investment Management’s Portfolio ENZ Stock Details ENZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-875,002	Closed	-$4.45M	–	245
2016 Q3	$4.45M	Buy	875,002 +17,060	+2%	+$102K	0.15%	157
2016 Q2	$5.12M	Sell	857,942 -25,730	-3%	-$143K	0.19%	151
2016 Q1	$4.02M	Sell	883,672 -510,290	-37%	-$2.27M	0.15%	171
2015 Q4	$6.27M	Buy	1,393,962 +798,210	+134%	+$3.37M	0.22%	141
2015 Q3	$1.89M	Buy	595,752 +52,813	+10%	+$160K	0.06%	225
2015 Q2	$1.65M	Buy	542,939 +276,451	+104%	+$777K	0.05%	225
2015 Q1	$786K	Sell	266,488 -9,070	-3%	-$29.7K	0.02%	228
2014 Q4	$1.22M	Sell	275,558 -24,795	-8%	-$118K	0.04%	199
2014 Q3	$1.55M	Buy	+300,353	New	+$1.6M	0.05%	198

Other funds holding ENZ

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

EGA

Evermore Global Advisors Summit, New Jersey $26.3M AUM 7.42% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

FLAM

First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return

GGHC

Gilder Gagnon Howe & Co New York $9.69B AUM 55.7% 1-Year Est. Return

Granahan Investment Management's ENZ Position: Q4 2016 in Review

Granahan Investment Management sold out of Enzo Biochem, Inc. (ENZ) in Q4 2016, closing a stake of 875,002 shares — an estimated $4.45M sold.

Granahan Investment Management first reported a position in ENZ in Q3 2014 and held it in 9 quarters. The position peaked at $6.27M in Q4 2015. 109 funds tracked by Wall St. Rank hold ENZ as of Q4 2016.

Granahan Investment Management reported no remaining Enzo Biochem, Inc. position as of Q4 2016 after selling out during the quarter.
Granahan Investment Management sold 875,002 Enzo Biochem, Inc. shares in Q4 2016, an estimated $4.45M.
Granahan Investment Management first reported a position in Enzo Biochem, Inc. in Q3 2014 and held it in 9 quarters.
Granahan Investment Management's Enzo Biochem, Inc. position peaked at $6.27M in Q4 2015.
109 funds tracked by Wall St. Rank held Enzo Biochem, Inc. as of Q4 2016.

Based on Granahan Investment Management's 13F filing for Q4 2016, filed 14 Feb 2017.